The polyphyrias: Characteristics and laboratory tests

Regulatory Toxicology and Pharmacology

Volumn 24, Issue 1 II, 1996, Pages

  Ellefson, R D ^a   Ford, R E ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; PORPHOBILINOGEN; PORPHYRIN;

BLOOD ANALYSIS; CONFERENCE PAPER; FECES ANALYSIS; HEREDITY; HUMAN; NEUROLOGIC DISEASE; PORPHYRIA; PRIORITY JOURNAL; URINALYSIS; BLOOD; CHEMICALLY INDUCED DISORDER; CHEMISTRY; ENVIRONMENTAL EXPOSURE; FECES; METABOLISM; PATHOPHYSIOLOGY; REVIEW; URINE;

AMINOLEVULINIC ACID; ENVIRONMENTAL EXPOSURE; FECES; HUMANS; PORPHOBILINOGEN; PORPHYRIAS; PORPHYRINS;

EID: 0029952104     PISSN: 02732300     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Ellefson, R. D. (1994). The porphyrias. Endocrinol. Metab. In-Service Train. Contin. Ed. 12, 265-279.
2. Kappas, A., Sassa, S., Galbraith, R. A., and Nordman, Y. (1995). The porphyrias. In The Metabolic Basis of Inherited Disease (C. R. Scriver, A. L. Beaudet, W. S. Sly, and D. Valle, Eds.), 7th ed., pp. 2103-2159. McGraw-Hill, New York.
3. Sassa, S. (1995). The porphyrias. In Williams Hematology (E. Beutler, M. A. Lichtman, B. S. Coller, and T. J. Kipps, Eds.), 5th ed., pp. 726-750. McGraw-Hill, New York.
4. McGillon, F. B., Moore, M. R., and Goldberg, A. (1973). The effect of L-aminolevulinic acid on the spontaneous activity of mice. Scott. Med. J. 18, 133.
5. Shanley, B. C., Neathling, A. C., Percy, V. A., and Carstens, M. (1975). Neurochemical aspects of porphyria: Studies on the possible neurotoxicity of L-aminolevulinic acid. S. Afr. J. Lab. Clin. Med. 49, 576-580.
6. Pierach, C. A., and Edwards, P. S. (1978). Neurotoxicity of L-aminolevulinic acid and porphobilinogen. Exp. Neurol. 62, 810-814.
7. Smith, B., and Prockop, D. J. (1962). Central nervous system effects of ingestion of L-tryptophan by normal subjects. N. Engl. J. Med. 267, 1338-1342.
8. Baloh, R. W., Dietz, J., and Spooner, J. W. (1982). Myoclonus and ocular oscillations induced by L-tryptophan. Ann. Neurol. 11, 95-97.
9. Windebank, A. J., and Bonkovsky, H. L. (1995). Porphyric neuropathy. In. Peripheral Neuropathy (P. J. Dyck and P. K. Thomas, Eds.), pp. 1161-1168. Saunders, Philadelphia.
10. Bloomer, J. R. (1979). Pathogenesis and therapy of liver disease in protoporphyria. Yale J. Biol. Med. 52, 39-48.
11. Ford R. E., and Ellefson, R. D. (1980). Assay for erythrocyte uroporphyrinogen I synthase activity with porphobilinogen as substrate. Clin. Chem. 26, 1182-1185.
12. Sassa, S., Zalar, G. L., and Kappas, A. (1978). Studies in porphyria VII. Induction of uroporphyrinogen I synthase and expression of the gene defect of acute intermittent porphyria in mitogen-stimulated human lymphocytes. J. Clin. Invest. 61, 499-508.
13. Grandchamp, B., and Nordmann, Y. (1977). Decreased lymphocyte coproporphyrinogen III oxidase activity in hereditary coproporphyria. Biochem. Biophys. Res. Commun. 74, 1089-1095.
14. Grandchamp, B., Deybach, J. C., Grelier, M., de Verneuil, H., and Nordmann, Y. (1980). Studies of porphyrin synthesis in fibroblasts of patients with congenital erythropoietic porphyria and one patient with homozygous coproporphyria. Biochim. Biophys. Acta 629, 577-586.
15. Ellefson, R. D., and Ford, R. E. Coproporphyrinogen oxidase activity in circulating human erythrocytes. In preparation.
16. Chan, R. Y., Schulman, H. M., and Ponka, P. (1993). Expression of ferrochelatase MRNA in erythroid and non-erythroid cells. Biochem. J. 292, 343-349.
17. Schwartz, S., Dahl, J., Ellefson, M., and Ahlquist, D. (1983). The "HemoQuant" test: A specific and quantitative determination of heme (hemoglobin) in feces and other materials. Clin. Chem. 29, 2061-2067.
18. Lindblad, B., Lindstedt, S., and Steen, G. (1977). On the genetic defects in hereditary tyrosinemia. Proc. Natl. Acad. Sci. USA 74, 4641-4645.
19. Tschudy, D. P., Hess, R. A., and Frykholm, B. D. (1981). Inhibition of L-aminolevulinic acid dehydratase by 4,6-dioxoheptanoic acid. J. Biol. Chem. 256, 9915-9923.
20. Sassa, S., and Kappas, A. (1983). Hereditary tyrosinemia and the heme biosynthetic pathway. Profound inhibition of L-amino-levulinic acid dehydratase activity by succinylacetone. J. Clin. Invest. 71, 625-634.
21. Keczkes, K., and Farr, M. (1976). Bullous dermatosis of chronic renal failure. J. Dermatol. 95, 541-546.
22. Strik, J. J. T. W. A. (1979). The occurrence of chronic hepatic porphyria in man caused by halogenated hydrocarbons. In Chemical Porphyria in Man (J. J. T. W. A. Strik and J. H. Kolman, Eds.), pp. 3 -9. Elsevier/North-Holland Biomedical Press, Amsterdam.
23. Doss, M. (1979). Chronic hepatic porphyrias in humans (endogenic factors). In Chemical Porphyria in Man. (J. J. T. W. A. Strik and J. H. Kolman, Eds.), pp. 11-26. Elsevier/North-Holland Biomedical Press, Amsterdam.
24. Doss, M. O. (1987). Porphyrinurias and occupational disease. In Mechanisms of Chemical-Induced Porphyrinopathies (Ellen K. Silbergeld and Bruce A. Fowler, Eds.). Ann. N.Y. Acad. Sci. 514, 204-218.
25. Schmid, R. (1960). Cutaneous porphyria in Turkey. N. Engl. J. Med. 263, 397-400.
26. Poland, A. P., Smith, D., Metter, G., and Possick, P. (1971). A health survey of workers in a 2,4-D and 2,4,5-T plant. Arch. Environ. Health 22, 316-327.
27. Fujita, H., Koizumi, A., Yamamoto, M., Kumai, M., Sadamoto, T., and Ikeda, M. (1984). Inhibition of L-aminolevulinate dehydratase in trichloroethylene-exposed rats, and the effects on heme regulation. Biochim. Biophys. Acta 800, 1-10.
28. Grannick, J. L., Sassa, S., Grannick, S., Levere, R. D., and Kappas, A. (1973). Studies in lead poisoning. II. Correlation between the ratio of activated to inactivated L-aminolevulinic acid dehydratase of whole blood and the blood lead level. Biochem. Med. 8, 149-159.
29. Astrim, K. H., Bishop, D. F., Wetmur, J. G., Kaul, B., Davidow, B., and Desnick, R. J. (1987). L-Aminolevulinic acid dehydratase isozymes and lead toxicity. In. Mechanisms of Chemical-Induced Porphyrinopathies (Ellen K. Silbergeld and B. A. Fowler, Eds.). Ann. N.Y. Acad. Sci. 514, 23-29.
30. Woods, J. S., and Fowler, B. A. (1987). Metal alteration of uroporphyrinogen decarboxylase and coproporphyrinogen oxidase. In Mechanisms of Chemical-Induced Porphyrinopathies (Ellen K. Silbergeld and B. A. Fowler, Eds.). Ann. N.Y. Acad. Sci. 514, 55-64.
31. Piomelli, S., Seaman, C., and Kapoor, S. (1987). Lead-induced abnormalities of porphyrin metabolism. The relationship with iron deficiency. In Mechanisms of Chemical-Induced Porphyrinopathies (Ellen K. Silbergeld and B. A. Fowler, Eds.). Ann. N.Y. Acad. Sci. 514, 278-288.
32. Cotter, P. D., Baumann, M., and Bishop, D. F. (1992). Enzymatic defect in "X-linked" sideroblastic anemia: Molecular evidence for erythroid L-aminolevulinate synthase deficiency. Proc. Natl. Acad. Sci. USA 89, 4028-4032.
33. Grossman, M. E., and Bickers, D. R. (1978). Porphyria cutanea tarda. A rare cutaneous manifestation of hepatic tumors. Cutis 21, 782-784.